Urinary Incontinence clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
Intradetrusor Botulinum Toxin A: Are Less Injections Better?
open to eligible females ages 18 years and up
Patients with either overactive bladder (OAB) or urgency urinary incontinence (UUI) with be randomized (like a flip of a coin) to receive 100 units of bladder Botox® at either one injection site or ten injection sites. Efficacy and patient satisfaction will be measured by questionnaires.
at UC Irvine
Our lead scientists for Urinary Incontinence research studies include Felicia Lane, MD.